Osteosarcoma (OSA) is a rare cancer in people. However OSA incidence rates in dogs are
27 times higher than in people. Prognosis in both species is relatively poor, with 5 year OSA …

Naturally occurring cancers in pet dogs and humans share many features, including
histological appearance, tumour genetics, molecular targets, biological behaviour and …

The use of chemical elixirs for the treatment of cancer can be traced through the medicinal
customs and practices of a number of cultures. 1 The modern use of pharmacologic agents …

Cisplatin is a platinum chemotherapeutic used in a variety of malignancies. The
antineoplastic activity occurs from DNA cross‐links and adducts, in addition to the …

Abstract Purpose: Recombinant Listeria vaccines induce tumor-specific T-cell responses
that eliminate established tumors and prevent metastatic disease in murine cancer models …

Osteosarcoma (OSA) is the most common type of bone tumors in dogs, which has high
metastasis ability. 80% of dogs with OSA die due to lung metastasis. As a result its treatment …

Osteosarcoma (OSA) is the most common primary bone tumour in dogs. The appendicular
locations are most frequently involved and large to giant breed dogs are commonly affected …

Osteosarcoma is by far the most common primary bone tumour in dogs, accounting for up to
85% of malignancies originating in the skeleton. This chapter covers osteosarcoma in dogs; …

Background Many chemotherapy protocols have been reported for treatment of canine
appendicular osteosarcoma (OSA), but outcome comparisons in a single population are …

Dogs with osteosarcoma provide an important model for the same disease in humans. In this
report, the comparative nature of human and canine osteosarcoma including incidence and …